<DOC>
	<DOCNO>NCT02503306</DOCNO>
	<brief_summary>Primary Objective : To assess change percent sexual attempt subject able maintain erection sufficient duration successful intercourse run-in period treatment period : - The change percent sexual attempt subject able insert penis partner 's vagina . - The change score erectile function ( EF ) domain International Index Erectile Function ( IIEF ) questionnaire . Secondary Objective : To evaluate safety tolerability avanafil patient erectile dysfunction ( ED ) .</brief_summary>
	<brief_title>Efficacy Tolerability Study Avanafil Russia</brief_title>
	<detailed_description>The total study duration per patient 12 week , consist 8-week treatment period 4-week run-in period .</detailed_description>
	<mesh_term>Erectile Dysfunction</mesh_term>
	<criteria>Inclusion criterion : Male subject , age â‰¥18 year . Minimum 6month history mild severe erectile dysfunction prior enrollment study . Subject monogamous , heterosexual relationship least 3 month prior enrollment study . Subject agrees make least 4 sexual intercourse attempt per month . Subject willing able provide inform consent . Exclusion criterion : Allergy hypersensitivity avanafil , sildenafil , vardenafil , tadalafil , component drug product . History doselimiting adverse effect therapy phosphodiesterase5 ( PDE5 ) inhibitor history consistent treatment failure PDE5 inhibitor therapy ED . Current expect use organic nitrate time study . Previous current ( include treatment ) antiandrogen therapy . Use ketoconazole , erythromycin , cimetidine , prescription overthecounter drug know inhibit activity cytochrome P450 ( CYP ) 3A4 within 28 day prior randomization time study . Androgen replacement therapy stable least 3 month . Erectile dysfunction result spinal cord injury radical prostatectomy . Untreated hypogonadism serum total testosterone &lt; 325 ng/dL ( early morning collection ) . History predisposition priapism ( sickle cell disease , blood dyscrasia , multiple myeloma ) . Uncontrolled hypertension evidence systolic blood pressure &gt; 170 mmHg diastolic blood pressure &gt; 100 mmHg screening . Hypotension evidence systolic blood pressure &lt; 90 mmHg diastolic blood pressure &lt; 50 mmHg screening . Orthostatic hypotension evidence reduction 20 mmHg systolic blood pressure , reduction 10 mmHg diastolic blood pressure , evidence cerebral hypoperfusion upon stand seat position . Clinically evident penile lesion , abrasion , anatomical deformity penile fibrosis , Peyronie 's disease , urinary tract bladder infection , sexually transmissible disease Investigator deem clinically significant . History drug , alcohol , substance abuse within 12 month entry . Partners &lt; 18 year age , nursing , know pregnant screening , wish become pregnant study period , dyspareunia , and/or gynecologic problem major medical condition would limit participation sexual intercourse . Evidence clinically significant medical , psychiatric , social , condition history , physical examination , laboratory study , opinion Investigator , would contraindicate administration study medication , affect compliance , interfere study evaluation , limit study participation , contraindicate sexual activity , confound interpretation study result . The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>